First experience with BCG discontinuation in Europe. Experience in Sweden 15 years after stopping general BCG vaccination at birth.
Romanus
V
V
Department of Epidemiology, National Bacterilogical Laboratory, Stockholm, Sweden.
D000293:Adolescent; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D010000:Osteitis / Q000209:etiology; D013548:Sweden / Q000453:epidemiology; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*
D001500:BCG Vaccine